Terms: = Leukemia AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
229 results:
1. Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in leukemia.
Pandey S; Singh R; Habib N; Tripathi RM; Kushwaha R; Mahdi AA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1121-1134. PubMed ID: 38679971
[TBL] [Abstract] [Full Text] [Related]
2. [Effects of BMAL2 on Aerobic Glycolysis and Cell Proliferation in Acute Myeloid leukemia Cells].
Jia WJ; Mu J; Cui WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):402-408. PubMed ID: 38660843
[TBL] [Abstract] [Full Text] [Related]
3. PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral Cancer Cells.
Yadav AK; Wang S; Shin YM; Jang BC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474118
[TBL] [Abstract] [Full Text] [Related]
4. HIF-1α/m
Cong X; Li X; Xu K; Yin L; Liang G; Sun R; Pu Y; Zhang J
Environ Int; 2024 Feb; 184():108493. PubMed ID: 38350257
[TBL] [Abstract] [Full Text] [Related]
5. Epigenetic drug screening for trophoblast syncytialization reveals a novel role for MLL1 in regulating fetoplacental growth.
Wu J; Qin C; Tian F; Liu X; Hu J; Wu F; Chen C; Lin Y
BMC Med; 2024 Feb; 22(1):57. PubMed ID: 38317232
[TBL] [Abstract] [Full Text] [Related]
6. New genetic drivers in hemorrhagic hereditary telangiectasia.
Cerdà P; Castillo SD; Aguilera C; Iriarte A; Rocamora JL; Larrinaga AM; Viñals F; Graupera M; Riera-Mestre A
Eur J Intern Med; 2024 Jan; 119():99-108. PubMed ID: 37689549
[TBL] [Abstract] [Full Text] [Related]
7. Promyelocytic leukemia protein regulates angiogenesis and epithelial-mesenchymal transition to limit metastasis in MDA-MB-231 breast cancer cells.
Vogiatzoglou AP; Spanou S; Sachini N; Drakos E; Nikolaou C; Makatounakis T; Kretsovali A; Papamatheakis J
Mol Oncol; 2023 Oct; 17(10):2090-2108. PubMed ID: 37518985
[TBL] [Abstract] [Full Text] [Related]
8. Mechanism of Procyanidin B2 in the Treatment of Chronic Myeloid leukemia Based on Integrating Network Pharmacology and Molecular Docking.
Li HX; Jing YX; Chai YH; Sun XH; He XX; Xue SL; Xi YM; Ma XL
Anticancer Agents Med Chem; 2023; 23(16):1838-1847. PubMed ID: 37246327
[TBL] [Abstract] [Full Text] [Related]
9. Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia.
Gayatri MB; Kancha RK; Patchva D; Velugonda N; Gundeti S; Reddy ABM
FEBS J; 2023 Sep; 290(18):4480-4495. PubMed ID: 37171230
[TBL] [Abstract] [Full Text] [Related]
10. Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia.
Wang X; Chen C; Vuong D; Rodriguez-Rodriguez S; Lam V; Roleder C; Wang JH; Kambhampati S; Berger A; Pennock N; Torka P; Hernandez-Ilizaliturri F; Siddiqi T; Wang L; Xia Z; Danilov AV
Leukemia; 2023 Jun; 37(6):1324-1335. PubMed ID: 37031300
[TBL] [Abstract] [Full Text] [Related]
11. Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca 2+ -dependent gap junction intercellular communication.
Li X; Xiao Y; Wang X; Huang R; Wang R; Deng Y; Rao J; Gao Q; Yang S; Zhang X
Chin Med J (Engl); 2023 Jan; 136(2):194-206. PubMed ID: 36801891
[TBL] [Abstract] [Full Text] [Related]
12. Gene expression of carbonic anhydrase 9 (CA9) in
Alyaqubi KJ; Dosh RH; Al-Fatlawi RB; Al-Rehemi SM; Hadi NR
J Med Life; 2022 Sep; 15(9):1158-1163. PubMed ID: 36415514
[TBL] [Abstract] [Full Text] [Related]
13. Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia.
Zhou H; Jiang Y; Huang Y; Zhong M; Qin D; Xie C; Pan G; Tan J; Deng M; Zhao H; Zhou Y; Tang Y; Lai Q; Fang Z; Luo Y; Jiang Y; Xu B; Zha J
Cancer Lett; 2023 Feb; 554():215997. PubMed ID: 36396101
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells.
Tsubaki M; Takeda T; Matsuda T; Kimura A; Tanaka R; Nagayoshi S; Hoshida T; Tanabe K; Nishida S
BMB Rep; 2023 Feb; 56(2):78-83. PubMed ID: 36195570
[TBL] [Abstract] [Full Text] [Related]
15. [Effect of Hypoxia on CD47 Expression in Human Acute Myeloid leukemia Cell Lines].
Wang CY; Li JP; Nan YY; Li QY; Xiang Y; Liu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):979-983. PubMed ID: 35981350
[TBL] [Abstract] [Full Text] [Related]
16. PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1α expression.
Zhu Y; Liu Z; Wan Y; Zou L; Liu L; Ding S; Lu C; Qiu F
Clin Immunol; 2022 Sep; 242():109094. PubMed ID: 35944879
[TBL] [Abstract] [Full Text] [Related]
17. XBP1 Regulates the Transcription of HIF-1a in BALB/c Mice with Chronic Rhinosinusitis without Polyps.
Qu X; Li H; Meng L
Anal Cell Pathol (Amst); 2022; 2022():3066456. PubMed ID: 35915851
[TBL] [Abstract] [Full Text] [Related]
18. The Increase in the Drug Resistance of Acute Myeloid leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins.
Kobyakova M; Lomovskaya Y; Senotov A; Lomovsky A; Minaychev V; Fadeeva I; Shtatnova D; Krasnov K; Zvyagina A; Odinokova I; Akatov V; Fadeev R
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887226
[TBL] [Abstract] [Full Text] [Related]
19. Long non-coding RNA DLEU1 promotes malignancy of breast cancer by acting as an indispensable coactivator for HIF-1α-induced transcription of CKAP2.
Ma HN; Chen HJ; Liu JQ; Li WT
Cell Death Dis; 2022 Jul; 13(7):625. PubMed ID: 35853854
[TBL] [Abstract] [Full Text] [Related]
20. Action Sites and Clinical Application of HIF-1α Inhibitors.
Xu R; Wang F; Yang H; Wang Z
Molecules; 2022 May; 27(11):. PubMed ID: 35684364
[TBL] [Abstract] [Full Text] [Related]
[Next]
